Alpha-defensin DEFA1A3 gene copy number elevation in Danish Crohn's disease patients

Digestive Diseases and Sciences

Volumn 56, Issue 12, 2011, Pages 3517-3524

  Jespersgaard, Cathrine ^a   Fode, Peder ^a   Dybdahl, Marianne ^a   Vind, Ida ^b   Nielsen, Ole Haagen ^b   Csillag, Claudio ^b   Munkholm, Pia ^b   Vainer, Ben ^c   Riis, Lene ^b   Elkjaer, Margarita ^b   Pedersen, Natalia ^b   Knudsen, Elisabeth ^d   Andersen, Paal Skytt ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Colonic tissue; Copy number variation; Crohn's disease; Defensin; Genetic association; Real time PCR

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN DEFA1; ALPHA DEFENSIN DEFA1A3; ALPHA DEFENSIN DEFA3; MESSENGER RNA; UNCLASSIFIED DRUG; CYCLOPEPTIDE; DEFA1A3 PROTEIN, HUMAN;

ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GENE DOSAGE; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROSEQUENCING; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; COPY NUMBER VARIATION; DENMARK; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; PREVALENCE; RISK FACTOR;

ALLELES; ALPHA-DEFENSINS; CROHN DISEASE; DENMARK; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PEPTIDES, CYCLIC; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 84856137706     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1794-8     Document Type: Article

References (39)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
3. Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol. 2009;3:513-534.
4. Yang D, de la RG, Tewary P, Oppenheim JJ. Alarmins link neutrophils and dendritic cells. Trends Immunol. 2009;30:531-537.
5. Leitch GJ, Ceballos C. A role for antimicrobial peptides in intestinal microsporidiosis. Parasitology. 2009;136:175-181.
6. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. Human defensins. J Mol Med. 2005;83:587-595. (Pubitemid 41176067)
7. Ericksen B, Wu Z, Lu W, Lehrer RI. Antibacterial activity and specificity of the six human alpha-defensins. Antimicrob Agents Chemother. 2005;49:269-275. (Pubitemid 40065802)
8. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710-720. (Pubitemid 41070812)
9. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935-2940. (Pubitemid 26055594)
10. Boniotto M, Jordan WJ, Eskdale J, et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother. 2006;50:1433-1441.
11. Grutkoski PS, Graeber CT, Lim YP, Ayala A, Simms HH. Alphadefensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 2003;47:2666-2668. (Pubitemid 36919478)
12. O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163:6718-6724.
13. Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut. 2007;56:1240-1247. (Pubitemid 47300425)
14. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA. 2005;102:18129-18134. (Pubitemid 41798513)
15. Soehnlein O, Kai-Larsen Y, Frithiof R, et al. Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest. 2008;118: 3491-3502.
16. Sthoeger ZM, Bezalel S, Chapnik N, Asher I, Froy O. High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology. 2009;127:116-122.
17. Yamaguchi N, Isomoto H, Mukae H, et al. Concentrations of alpha-and beta-defensins in plasma of patients with inflammatory bowel disease. Inflamm Res. 2009;58:192-197.
18. Cunliffe RN, Kamal M, Rose FR, James PD, Mahida YR. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol. 2002;55:298-304. (Pubitemid 34293399)
19. Linzmeier R, Ho CH, Hoang BV, Ganz T. A 450-kb contig of defensin genes on human chromosome 8p23. Gene. 1999;233: 205-211. (Pubitemid 29353240)
20. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet. 2003;73:591-600. (Pubitemid 37076271)
21. Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet. 2005;14:2045-2052. (Pubitemid 41418040)
22. Mars WM, Patmasiriwat P, Maity T, Huff V, Weil MM, Saunders GF. Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3. J Biol Chem. 1995; 270:30371-30376. (Pubitemid 26005089)
23. Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha-and beta-defensin regions at 8p22-p23. Genomics. 2005;86:423-430. (Pubitemid 43293155)
24. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79:439-448. (Pubitemid 44384253)
25. Bentley RW, Pearson J, Gearry RB, et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol. 2010;105:354-359.
26. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet. 2008;40:23-25.
27. Hollox EJ. Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res. 2008;123:148-155.
28. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
29. Csillag C, Nielsen OH, Borup R, Nielsen FC, Olsen J. Clinical phenotype and gene expression profile in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2007;292:G298-G304. (Pubitemid 46091632)
30. Vind I, Vieira A, Hougs L, et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion. 2005; 72:156-163. (Pubitemid 41507276)
31. Day DW, Jass JR, Price AB, et al. Morson and Dawson's gastrointestinal pathology. 4th ed. Oxford: Blackwell Science; 2003: 505-507.
32. Spiller R. Clinical update: irritable bowel syndrome. Lancet. 2007;369:1586-1588. (Pubitemid 46710110)
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408. (Pubitemid 34164012)
34. Nuytten H, Cuppens H, Verleden G. A high diploid DEFA1A3 copy number predispose to lung transplant rejection. J Heart Lung Transplant. 2009;28:S106.
35. Hollox EJ. Beta-defensins and Crohn's disease: confusion from counting copies. Am J Gastroenterol. 2010;105:360-362.
36. Ballana E, Gonzalez JR, Bosch N, Estivill X. Inter-population variability of DEFA3 gene absence: correlation with haplotype structure and population variability. BMC Genomics. 2007;8:14.
37. Blomqvist M, Bergquist J, Westman A, et al. Identification of defensins in human lymphocyte nuclei. Eur J Biochem. 1999;263: 312-318. (Pubitemid 29337020)
38. Dooley TP, Curto EV, Reddy SP, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004;10:1-14. (Pubitemid 38072439)
39. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet. 2009;18:R1-R8.